galileoisback

A "director's cut" to the IsraeLeak tape (https://rumble.com/v24i3gq-israeleak-full-tape.html), hosted by Dr. Yaffa Shir-Raz and Prof. Retsef Levi from the Israeli PECC. Yaffa and Retsef play selective sections from the tape, discuss the statements made by the participants in the meeting, and provide the broader context for the reason the study discussed at the meeting was commissioned, the implications of its findings, and the fact these findings were misrepresented in a public report while the study itself was discontinued. גרסת הבמאי לקלטת המודלפת מפגישת משרד הבריאות בנושא תופעות הלוואי מחיסוני הקורונה, בהנחיית דר' יפה שיר-רז ופרופ' רצף לוי ממועצת החרום הציבורית למשבר הקורונה. יפה ורצף מקרינים חלקים מהקלטת, דנים בדברים שנאמרים ע"י המשתתפים בפגישה, ומספקים הקשר נרחב לסיבות בגינן המחקר הוזמן, ההשלכות של ממצאי המחקר, והעובדה שממצאים אלו סולפו בדו"ח ציבורי בעוד המחקר עצמו הופסק.

In several occasions in the IsraeLeak tape, both parties express the importance of publishing the findings to the public. At the end of this edited clip which gathers such statements, Sasha, the de-facto main investigator, says how much relief she feels knowing these findings are finally going to be published. Well Sasha, maybe it is not as you originally intended it to happen, but we are glad to help! And without any sarcasm, thank you for the amazing work you did with this research, many people owe you a lot for your discoveries!

A segment of the IsraeLeak tape discussing the findings from the open field analysis. מקטע מתוך הקלטת העוסק בממצאים מניתוח השדות הפתוחים.

In a response to Reuters "Fact Checking" report to early releases from the IsraeLeak tape, an anonymous official in the IMoH claimed the tape contains "a preliminary attempt of a supporting team to understand from epidemiological experts how to continue and analyse the raw data in a correct manner". This edited clip highlights places in the tape that indicate the exact opposite. In fact, it was the research team who demonstrated a deeper understanding in the pharmacovigilance domain, which was applauded many times by the IMoH people. Now that the full tape is publicly available, we challenge that anonymous IMoH official and those Reuters "fact checkers" who presumably verified their statements, to point to the exact position in the tape in which they believe the research team is consulting with the IMoH team (rather than teaching them) about how to process the raw data... https://www.reuters.com/investigates/special-report/fact-check-hebrew-moh/

An edited clip from the IsraeLeak tape, showing how the researchers repeatedly emphasize the importance of continuing the study.

An edited clip from the IsraeLeak tape in which the investigators revile that most of the reports came only from one of the smaller Israeli HMOs, where the two bigger HMOs hardly provided any reports. This is an indication that the event counts reported in the system are most likely much smaller than the actual counts.

"...One of the strongest things here is the rechallenge we know about medications There is the Naranjo Scale (The Adverse Drug Reaction (ADR) probability scale): When there is an adverse event that recurs upon rechallenge It turns "it" from "possible" To "definite" and significant ..."

"Here, here we will need to think in a medico-legal way Why medico-legal way? Because for quite a few events we said Okay, they exist, There are reports But please get the vaccine Meaning, we need to think how we write it and present it in a correct way so that this will not yield court cases later on "wait a moment, you said that everything will pass and vaccination should continue" and now see what happened to me..."

The Public health director reassured the public that all menstrual irregularities are passing. This is not what their appointed researchers team found.

נקיפות מצפון של חוקרים ומי זו השרון שהם מחפשים? הערב סרטון נוסף מהדיון הסגור במשרד הבריאות אז סוף סוף, אחרי שנה שלמה שבה למדינת ישראל, "המעבדה של העולם", לא הייתה מערכת דיווח תופעות לוואי מתפקדת – השנה הקריטית שבה ניתן החלק הארי של המנות לרוב הישראלים – משרד הבריאות השיק בדצמבר 2021 מערכת דיווח חדשה. סוף סוף, החוקרים שמשרד הבריאות שכר כדי לנתח את הנתונים מדיווחי תופעות הלוואי עומדים להציג בפני בכירי המשרד את ממצאי הניתוח שלהם. מדוע יו״ר ועדת המעקב לבטיחות ויעילות חיסוני הקורונה לא לוקחת חלק בפגישה הקריטית הזו? מדוע הצוות צריך לבקש כמה פעמים לפגוש ולהציג את הממצאים לשרון? ומדוע המצפון של אנשי משרד הבריאות לא מייסר אותם על כך שהם לא משתפים את המידע החמור הזה, כמו שהוא מייסר חוקרים? רק נזכיר שבהסכם שיתוף הפעולה המחקרי עם פייזר לא מוגדרים שום אלמנטים הקשורים בניטור תופעות לוואי.

A recording of a meeting which took place on June 8th 2022 between Prof. Matti Berkovitch's research team and representatives of the Israeli Ministry of Health (IMoH). The research team was commissioned to analyze data from a Covid 19 vaccine safety reporting system, which was launched late December 2021 after the IMoH had realized its original system used throughout 2020 is dysfunctional. In the meeting, the team shared its findings from analyzing 6-month data from late December 2021 to the end of May 2022. The team identified previously unknown adverse reactions related to the vaccine, including neurological, menstrual, bone-muscle, and digestive disorders. It has also identified high rates of long lasting effects for adverse reactions which were previously thought to have only short-term effects. Moreover, due to a "rechallenge" phenomenon, i.e. the fact that in a significant portion of the reports the adverse reactions reoccurred or intensified with additional vaccine doses, the research team claimed to have strong evidence that these adverse reactions are causally linked to the vaccine. הקלטה של פגישת זום שנערכה ב-8 ביוני 2022 בין נציגי משרד הבריאות וצוות המחקר של פרופ' מתי ברקוביץ'. על צוות המחקר הוטל לנתח נתונים מתוך מערכת דיווח תופעות לוואי לחיסוני הקורונה, אשר הושקה בסוף דצמבר 2021 אחרי שהתברר למשרד הבריאות שהמערכת המקורית שפעלה לאורך 2021 לא מאפשרת ניתוח אפקטיבי של הנתונים. בפגישה הצוות חולק את הממצאים שלו מתוך ניתוח נתונים שנאספו במשך כחצי שנה, מסוף דצמבר 2021 ועד סוף מאי 2022. הצוות זיהה תופעות לוואי הקשורות לחיסון שלא היו ידועות בעבר, כולל תופעות נוירולוגיות, הפרעות במחזור הווסת, בעיות שריר-שלד, ובעיות במערכת העיכול. כמו כן זוהו מקרים רבים של של תופעות ארוכות טווח אשר עד כה נחשבו לתופעות קצרות וחולפות. בנוסף, בשל תופעת ה"ריצ'אלנג'", כלומר העובדה שבמספר משמעותי של דיווחים על תופעות לוואי התופעה חזרה או התחזקה עם מנות נוספות של החיסון, צוות המחקר טען כי זאת ראיה חזקה לכך כי יש קשר סיבתי בין החיסון לתופעות אלו.

"Medico-legal" "Rechallenge proves causality" "Only one HMO reported" "Guilt conscience" "Temporary and passing?" "No new signal?" "I am in charge"

Only one small HMO which covers roughly 15% of the Israelis, actually passed their (6 months) reports to the reseachers' team. This did not prevent the IMOH from calculating prevalence of AE by dividing to total doses given across all HMO's and since Dec 2020...

The principle investigator Prof. Berkovich expresses his fear, based on past experience, that the agreement will not be met regarding funding the study.

An edited clip, containing segments in the tape in which the investigators say they have found new safety signals for the Covid-19 vaccines, including previously unknown adverse reactions, as well as known adverse reactions which were previously assumed to have only short-term effect but were reviled to have in many cases long-lasting one.

An edited clip, containing segments in the tape in which the investigators explicitly state their analyses can establish causal relations between the Covid-19 vaccines and adverse reactions.

A representative part of the discussion taken place in the meeting. Among the discussed topics: - The participants express their wishes to publish the current findings; - The fact previously unknown adverse reactions with causal relations to the vaccines were identified; - The need to update Pfizer regarding previously unknown long-term adverse reactions; - Thinking "Medico-Legal" regarding how these findings should be presented to the public.

At the FDA: Prof Retsef Levi “And please understand that the adverse events surveillant system in Israel is truly dysfunctional, particularly around the booster deployment. I know from personal experience that the Ministry of Health in Israel does not address appropriately major concerning safety signals.” Alroy Preis: p 258 https://youtu.be/WFph7-6t34M?t=21445 I have to say that I was pretty surprised with Retsef Levi’s comment that Israel doesn’t follow adverse events. It’s our data, I’m in charge of it, so I know exactly what is being reported to us. And I set our reservation. But we actually have two very large studies from our biggest HMOs that covered 75 percent of the population. And they looked into adverse events in Maccabi and Clalit. They looked at adverse events one week following the third dose in those who are 60 plus. And they saw the same thing we saw, that there was the same -- there was some local and systemic adverse events but not serious adverse events. Most people said that they felt like they felt after the second dose, between 80 percent to 90 percent said they felt like after the second dose, and about 10 percent said that they felt worse but there was no adverse event. And about 1 percent went to seek medical help because they didn’t feel well. So it’s really not significantly different than what we saw on the second dose. So the adverse event from the third booster dose, based on our 3 million vaccinees -- and I have to say again, part of them have not -- we haven’t followed for 30 days. Because we just rolled for the younger adults recently. But for the older people we have passed 30 days and this is the profile that we’re seeing. Pretty safe. And we saw an increase in -- dramatic increase in their protection against disease. So the risk of them having disease with complication reduce significantly. DR. ARNOLD MONTO: Thank you. DR. JAY PORTNOY: So adverse events might have been less than the risk of getting those same events if they were not vaccinated and they just got the disease. DR. SHARON ALROY-PREIS: So what we saw prior to our booster campaign was that the 60 percent of the people in severe and critical conditions were immunized, doubly immunized, fully vaccinated. And as I said,45 percent of people who died in this fourth wave were doubly vaccinated. So there was a huge importance of this booster effect not to just to reduce confirmed cases but actually to save lives for those who are getting the disease and those who are getting the severe and critical conditions. DR. JAY PORTNOY: Thank you. DR. ARNOLD MONTO: Thank you. We’re moving on to Dr. Levi. [this is incorrectly attributed to Dr. Retsef Levi, should be Dr. Ofer Levi) https://youtu.be/WFph7-6t34M?t=21618

In contrast to the researchers' findings and conclusions presented to them – the IMoH blatantly claimed in the report that there were NO NEW SIGNALS found in the study that are not already known.

After they commissioned an external research team to analyze the reports on adverse events, only at the end of 2021, it seems like the Israel Ministry of Health decided to put a stop on the study because it did not like the findings. Apparently, one of the findings the Ministry did not like is 155 reports of serious side effects among adults over 18 years of age, which led to hospitalizations or ER visits. These 155 reports on serious adverse events represent a very high reporting rate, especially given the fact they were collected only from less than 15 percent of the population and over a year after the vaccination campaign in Israel started. During the study, the researchers identified 173 such reports, including 19 cases in children up to the age of 17 and 155 reports of serious cases in adults age 18 and older. However the researchers explained that during the study they were only able to analyze the reporting of hospitalizations and ER referrals in children. "We collected the data, gathered using the form regarding cases of hospitalization and emergency room admission That is to say, those who reported indicated whether they were hospitalized or went to ER. We entered it into the Ofek system. We did not enter all the cases of hospitalization and ER addmissions, only for those who are in this age range, for patients that reported From the age of five.. children up to the age of 17. We actually collected the relevant medical information around that vaccine. This information was collected, and was concentrated in a dedicated form. And later it was actually sent to committee members who servied the case before the comitee convened. And at the end of the committee, after the conclusions were received, we consolidated the conclusions of the committee, and sent it to all the members." As can be seen, these are serious cases of hospitalization due to side effects such as myocarditis and pericarditis in small children On the other hand, as professor Mati Berkowitz, head of the research team explains: The team has not yet had time to analyze reports on equally serious events, including cardio-vascular events among 155 adults. By the way, there is another topic of the team meetings.. the E12 team and the children's team, Sasha also summarized them And I think it adds a lot. If we talk about the future, look there are a hundred and fifty-five Reports of major- i.e. hospitalization or ER admissions of adults, there is no doubt that it is in place to do it just like we did with the children. MOH prevents the analysis of cases of the most serious AE, which is serious in light of the fact that this is a non-anonymous form so that the cases are identified and can be followed and examined in depth. Moreover, the MOH removed from the formal report it issued in August 2022 any trace of those 155 cases of serious side effects that required hospitalization or ER visits in adults. The researchers explain to the Ministry of Health during the discussion that they have not yet had time to analyze the reports of additional AE they have identified, including heart problems that were reported with high frequency among men. In this meeting, I will discuss the most common affects, O.K.? We have here a database of information that we haven't touched and still haven't analyzed We see here, that there is a significant part of disorders in the menstrual cycle for females. And here in men we suddenly saw cardiovascular effects that were.. that reached 14 percent of all the phenomena reperted by males and they did not appear in the female's data. When the findings of the teams' study contradict the Ministry of Health's "safe and effective" narrative, instead of changing its approach, the Ministry of Health decided to halt the study, delete any evidence of new signals, re-challenge or long-term side effects, including the 155 reports of serious side effects in adults that required hospitalization or ER visits – and bury the conclusions. "..the most important thing in my opinion Emil .. is to publish.. to share this with Sharon, Nachman Ash (heads of MOH), they.. I'm looking now also at our common target audience, to continue this venture. It is a shame not to continue it. A shame!"